title: Immunotherapy with histamine dihydrochloride and low-dose interleukin-2 favors sustained lymphocyte recovery in acute myeloid leukemia.
authors.affiliation: Sahlgrenska Cancer Center, University of Gothenburg, Gothenburg, Sweden.
authors.forename: Alexander
authors.initials: A
authors.lastname: Hallner
authors.forename: Johan
authors.initials: J
authors.lastname: Aurelius
authors.forename: Fredrik Bergh
authors.initials: FB
authors.lastname: Thorén
authors.forename: Frida Ewald
authors.initials: FE
authors.lastname: Sander
authors.forename: Mats
authors.initials: M
authors.lastname: Brune
authors.forename: Kristoffer
authors.initials: K
authors.lastname: Hellstrand
authors.forename: Anna
authors.initials: A
authors.lastname: Martner
mesh_terms: D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000097:blood* / Q000473:pathology*; D018655:Lymphocyte Count; D008297:Male